Holding(s) in Company
June 30 2004 - 10:49AM
UK Regulatory
RNS Number:3190A
Cambridge Antibody Tech Group PLC
30 June 2004
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1) Name of company
Cambridge Antibody Technology Group plc
2) Name of shareholder having a major interest
Human Genome Sciences Inc
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them
Not disclosed
5) Number of shares/amount of stock acquired
n/a
6) Percentage of issued class
n/a
7) Number of shares/amount of stock disposed
Not disclosed
8) Percentage of issued class
Not disclosed
9) Class of security
Ordinary 10 pence shares
10) Date of transaction
Not disclosed
11) Date company informed
30 June 2004
12) Total holding following this notification
Not disclosed
13) Total percentage holding of issued class following this notification
Not disclosed
14) Any additional information
Human Genome Sciences Inc have notified the Company that their interest in the
CompanyOs securities has fallen below 3% and that they therefore do not have a
notifiable interest under sections 198-204 of the Companies Act 1985.
15) Name of contact and telephone number for queries
Justin Hoskins 01223 898589
16) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of notification 30 June 2004
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEALKEDLXLEFE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
